Suspension of trading

Transcripts scPharmaceuticals Inc.

Stocks

SCPH

US8106481059

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2025-10-06 EDT			5-day change	1st Jan Change
5.670 ^USD	-.--%		-.--%	-

25-10-07	MannKind Corporation completed the acquisition of scPharmaceuticals Inc..	CI
25-10-07	MannKind Completes Acquisition of scPharmaceuticals	MT

Transcripts

25-08-25	MannKind Corporation, scPharmaceuticals Inc. - M&A Call
25-08-08	ScPharmaceuticals Inc., Q2 2025 Earnings Call, Aug 07, 2025
25-05-14	ScPharmaceuticals Inc., Q1 2025 Earnings Call, May 14, 2025
25-03-19	ScPharmaceuticals Inc., Q4 2024 Earnings Call, Mar 19, 2025
24-11-13	ScPharmaceuticals Inc., Q3 2024 Earnings Call, Nov 13, 2024
24-10-22	ScPharmaceuticals Inc. - Special Call
24-08-14	ScPharmaceuticals Inc., Q2 2024 Earnings Call, Aug 14, 2024
24-05-14	ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024
24-03-13	ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024
23-11-08	ScPharmaceuticals Inc., Q3 2023 Earnings Call, Nov 08, 2023
23-08-10	ScPharmaceuticals Inc., Q2 2023 Earnings Call, Aug 10, 2023
23-05-10	ScPharmaceuticals Inc., Q1 2023 Earnings Call, May 10, 2023
23-03-22	ScPharmaceuticals Inc., Q4 2022 Earnings Call, Mar 22, 2023
22-11-09	ScPharmaceuticals Inc., Q3 2022 Earnings Call, Nov 09, 2022
22-08-09	ScPharmaceuticals Inc. Provides Earnings Guidance for the Year of 2022	CI
22-07-13	ScPharmaceuticals Inc. - Special Call
22-05-16	ScPharmaceuticals Inc. Provides Earnings Guidance for the Year 2022	CI
22-03-22	Scpharmaceuticals Inc. Provides Earnings Outlook for the Year 2022	CI
21-07-14	scPharmaceuticals Inc. - Special Call
21-05-12	Scpharmaceuticals Inc. Announces Earnings Guidance for 2021	CI
21-03-23	Scpharmaceuticals Inc. Provides Earnings Forecasts for the Year 2021	CI
21-03-04	scPharmaceuticals Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-04-2021 10:30 AM
20-08-13	ScPharmaceuticals Inc. Provides Net Loss Guidance for 2020	CI
20-06-09	scPharmaceuticals Inc. - Shareholder/Analyst Call
19-06-18	scPharmaceuticals Inc. - Shareholder/Analyst Call